Overview

  • Product nameAnti-CARKL antibody
    See all CARKL primary antibodies
  • Description
    Rabbit polyclonal to CARKL
  • Tested applicationsSuitable for: WB, ELISA, IHC-Pmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat
  • Immunogen

    Synthetic peptide derived from the N-terminal of human CARKL.

  • Positive control
    • Human liver carcinoma tissue. Extracts from Jurkat cells.

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab69920 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Detects a band of approximately 52 kDa (predicted molecular weight: 52 kDa).
ELISA 1/20000.
IHC-P 1/50 - 1/100.

Target

Anti-CARKL antibody images

  • All lanes : Anti-CARKL antibody (ab69920) at 1/500 dilution

    Lane 1 : Extracts from Jurkat cells
    Lane 2 : Extracts from Jurkat cells with immunising peptide at 5 µg

    Lysates/proteins at 5 µg per lane.


    Predicted band size : 52 kDa
    Observed band size : 52 kDa
  • Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue using ab69920 at 1/50 dilution, in the presence and absence of immunising peptide.

References for Anti-CARKL antibody (ab69920)

This product has been referenced in:
  • Haschemi A  et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 15:813-26 (2012). WB ; Mouse . Read more (PubMed: 22682222) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab69920.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"